168 related articles for article (PubMed ID: 36549762)
1. Association between statin therapy and the risk of stroke in patients with moyamoya disease: a nationwide cohort study.
Yoo J; Jeon J; Baik M; Kim J
Stroke Vasc Neurol; 2023 Aug; 8(4):276-283. PubMed ID: 36549762
[TBL] [Abstract][Full Text] [Related]
2. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053
[TBL] [Abstract][Full Text] [Related]
3. Is statin therapy after ischaemic stroke associated with increased intracerebral hemorrhage? The association may be dependent on intensity of statin therapy.
Yang R; Wu J; Yu H; Wang S; Chen H; Wang M; Qin X; Wu T; Wu Y; Hu Y
Int J Stroke; 2023 Oct; 18(8):948-956. PubMed ID: 37070670
[TBL] [Abstract][Full Text] [Related]
4. Intravenous thrombolysis and endovascular thrombectomy for acute ischaemic stroke in patients with Moyamoya disease - a systematic review and meta-summary of case reports.
Koh MY; Toh KZ; Ho JS; Yeo LL; Ho AF; Sia CH; Tan BY
J Thromb Thrombolysis; 2022 Aug; 54(2):339-349. PubMed ID: 35699873
[TBL] [Abstract][Full Text] [Related]
5. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
Lee J; Lee S
Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
[TBL] [Abstract][Full Text] [Related]
6. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
[TBL] [Abstract][Full Text] [Related]
7. Effects of Statin Intensity and Adherence on the Long-Term Prognosis After Acute Ischemic Stroke.
Kim J; Lee HS; Nam CM; Heo JH
Stroke; 2017 Oct; 48(10):2723-2730. PubMed ID: 28916672
[TBL] [Abstract][Full Text] [Related]
8. Effects of Statin Therapy on the Risk of Intracerebral Hemorrhage in Korean Patients with Hyperlipidemia.
Jung M; Lee S
Pharmacotherapy; 2019 Feb; 39(2):129-139. PubMed ID: 30585646
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of moyamoya disease versus atherosclerosis-associated moyamoya vasculopathy using high-resolution MR vessel wall imaging.
Lu M; Zhang H; Liu S; Liu D; Peng P; Hao F; Yuan F; Liu Y; Sheng F; Zhang L; Zhao X; He Y; Han C; Cai J
J Neurol Neurosurg Psychiatry; 2023 Jul; 94(7):567-574. PubMed ID: 36868848
[TBL] [Abstract][Full Text] [Related]
10. Patient-related characteristics associated with non-persistence with statin therapy in elderly patients following an ischemic stroke.
Wawruch M; Zatko D; Wimmer G; Luha J; Hricak V; Murin J; Kukumberg P; Tesar T; Hloska A; Shah R
Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):201-207. PubMed ID: 27935151
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of and Risk Factors for Cerebral Microbleeds in Moyamoya Disease and Syndrome in the American Population.
Khan NI; Saherwala AA; Chen M; Salehian S; Salahuddin H; Welch BG; Pinho MC; Shang T
Cerebrovasc Dis Extra; 2019; 9(3):139-147. PubMed ID: 31830749
[TBL] [Abstract][Full Text] [Related]
12. Statin therapy after first stroke reduces 10-year stroke recurrence and improves survival.
Milionis HJ; Giannopoulos S; Kosmidou M; Panoulas V; Manios E; Kyritsis AP; Elisaf MS; Vemmos K
Neurology; 2009 May; 72(21):1816-22. PubMed ID: 19470963
[TBL] [Abstract][Full Text] [Related]
13. Lack of Statin Therapy and Outcomes After Ischemic Stroke: A Population-Based Study.
Åivo J; Ruuskanen JO; Tornio A; Rautava P; Kytö V
Stroke; 2023 Mar; 54(3):781-790. PubMed ID: 36748465
[TBL] [Abstract][Full Text] [Related]
14. Statins Reduce Bleeding Risk in Patients Taking Oral Anticoagulants for Nonvalvular Atrial Fibrillation: A Retrospective Registry Study.
Uchida K; Ueda S; Sakakibara F; Kinjo N; Nezu M; Arai H; Morimoto T
Am J Cardiovasc Drugs; 2023 Jan; 23(1):89-99. PubMed ID: 36380115
[TBL] [Abstract][Full Text] [Related]
15. Ten-year follow-up investigation of stroke risk in systemic lupus erythematosus.
Huang JA; Lin CH; Wu MJ; Chen YH; Chang KC; Hou CW
Stroke Vasc Neurol; 2024 Feb; 9(1):1-7. PubMed ID: 37169398
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet therapy may improve the prognosis of patients with moyamoya disease: a 12-year retrospective study.
Luo Y; Cao Z; Ye H; Wu S; Sun X
J Neurol; 2023 Aug; 270(8):3876-3884. PubMed ID: 37106259
[TBL] [Abstract][Full Text] [Related]
17. Associations of HDL-C/LDL-C with myocardial infarction, all-cause mortality, haemorrhagic stroke and ischaemic stroke: a longitudinal study based on 384 093 participants from the UK Biobank.
Yuan S; Huang X; Ma W; Yang R; Xu F; Han D; Huang T; Peng M; Xu A; Lyu J
Stroke Vasc Neurol; 2023 Apr; 8(2):119-126. PubMed ID: 36150733
[TBL] [Abstract][Full Text] [Related]
18. High-intensity versus moderate-intensity statin treatment for patients with ischemic stroke: Nationwide cohort study.
Bach F; Skajaa N; Esen BÖ; Fuglsang CH; Horváth-Puhó E; Sørensen HT; Adelborg K
Eur Stroke J; 2023 Dec; 8(4):1041-1052. PubMed ID: 37555324
[TBL] [Abstract][Full Text] [Related]
19. Hyperlipidemia is associated with lower risk of poststroke mortality independent of statin use: A population-based study.
Yeramaneni S; Kleindorfer DO; Sucharew H; Alwell K; Moomaw CJ; Flaherty ML; Woo D; Adeoye O; Ferioli S; de Los Rios La Rosa F; Martini S; Mackey J; Khatri P; Kissela BM; Khoury JC
Int J Stroke; 2017 Feb; 12(2):152-160. PubMed ID: 27649737
[TBL] [Abstract][Full Text] [Related]
20. Cerebrovascular events after surgery versus conservative therapy for moyamoya disease: a meta-analysis.
Wouters A; Smets I; Van den Noortgate W; Steinberg GK; Lemmens R
Acta Neurol Belg; 2019 Sep; 119(3):305-313. PubMed ID: 31215004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
